Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant (B.1.1.529)C including includes recombinant Omicron Spike proteins (RBD, S1, and S-ECD trimer), monoclonal antibodies recognizing the Omicron Spike protein, and the Omicron pseudovirus assay CRO service.